Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Practice Membership
Public Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD.
Patents Assigned to HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD.
RNA adeno-associated virus (RAAV) vector and uses thereof
Patent number:
12031148
Abstract:
The invention described herein provides a recombinant DNA viral particle comprising a protein shell encapsulating an RNA vector genome, as well as related compositions and uses thereof.
Type:
Grant
Filed:
June 9, 2022
Date of Patent:
July 9, 2024
Assignee:
HUIDAGENE THERAPEUTICS (SINGAPORE) PTE. LTD.
Inventors:
Linyu Shi, Weiya Bai